• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Imaging scientists back MR to detect ductal carcinoma

Publication
Article
Diagnostic ImagingDiagnostic Imaging Vol 31 No 11
Volume 31
Issue 11

MRI, possibly employing higher field strengths and dedicated breast coils, should be used more often for detecting ductal carcinoma in situ, according to a panel convened by the National Institutes of Health.

MRI, possibly employing higher field strengths and dedicated breast coils, should be used more often for detecting ductal carcinoma in situ, according to a panel convened by the National Institutes of Health.

MRI is used for adjunct screening in women at high risk, but could gain significance when diagnosing DCIS, according to a Sept. 24 statement issued by the panel. The experts recommended looking at how higher field strength magnets and dedicated breast coils might improve detection. They also called for comparative effectiveness studies in individuals who do and do not undergo MRI. The comments came in a conference sponsored by the NIH and the National Cancer Institute.

Recent Videos
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 2
Related Content
© 2025 MJH Life Sciences

All rights reserved.